BRCA2 and familial pancreatic carcinoma: Pancreatic cancer patients with a family history of pancreatic cancer have a higher prevalence of BRCA2 gene mutation than pancreatic cancer patients without a family history of pancreatic cancer (17–19% [108,109] vs. 5–10% [110,111], respectively).